Logos of Alcon and Lumithera
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

Alcon announced its intention to acquire LumiThera and its PBM device for the treatment of…